In addition, they support the idea that the low cytotoxicity induced by ACE preparations from Ova-4 and Ova-5 HER-2/neu− primary tumours should rather be attributed to an inadequate recognition of tumour targets than to qualitative differences in cytokine secretion profiles by the MEAMNC effectors. This evidence concerns the gene ACE and neoplasm.